Accreditations & Approvals

Venus Remedies Ltd. recently received Marketing Authorization (MA) to market our generic antibiotic, Meropenem, in Spain. This significant achievement marks a major milestone for the organization and reinforces our commitment to providing high-quality healthcare solutions globally. The approval from the Spanish regulator is a testament to the rigorous research, development,

Venus Remedies, a leading pharmaceutical company dedicated to improving global healthcare, has achieved yet another milestone. We have recently received the prestigious Good Manufacturing Practice (GMP) approval from Ukraine for our state-of-the-art Carbapenem and Oncology Parenteral facilities at our unit in Baddi. The GMP certification is a testament to our

Venus Remedies has received Good Manufacturing Practices (GMP) certification from the Kenya Pharmacy and Poisons Board for all its production facilities located in Baddi, Himachal Pradesh. This certification recognizes Venus Remedies' commitment to maintaining high-quality standards in manufacturing pharmaceutical products. The GMP certification is a crucial milestone for Venus as

Venus Remedies has recently achieved a significant milestone by obtaining marketing authorizations for two of its groundbreaking cancer drugs in Iraq and Philippines. This recent development not only underscores the company's commitment to improving global healthcare but also highlights its growing presence in the Middle East. Venus Remedies has long

Thrilled to share a remarkable achievement by Venus Remedies, as it proudly expands its global footprint in the field of oncology. With a recent contract win in Ukraine, Venus Remedies has taken a significant step towards combating cancer in a nation ravaged by war. This momentous occasion signifies our commitment